Not checkedNot checked for notices yet.
Hepatitis C drug prescriptions and Medicaid policies--four states, Indian health care system, USA 2018
Brigg Reilley, Matt Miller, Matt Hudson and 2 more
International Journal for Equity in Health · 2019
doi:10.1186/s12939-019-1101-4 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Abstract Medicaid, the state-level public insurance in the United States, has widely differing criteria treatment for hepatitis C virus (HCV) such as stage of liver fibrosis, documented sobriety, and specialist consultation. In a rural health network, facilities located in two less restrictive states prescribed HCV drugs at a significantly higher rate than two more restrictive states (rate ratio 4.7, CI 2.6–8.5). Prescription rates per population were highly associated with HCV treatment policies.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.